Drug profile · INN
measles, mumps and rubella vaccine (live)
M-M-RVAXPRO
measles, mumps and rubella vaccine (live) (M-M-RVAXPRO) is an FDA-listed pharmaceutical active ingredient.
EMA: approved Antiinfectives for systemic use (J07) J07BD52
Patents linked 0
Pipeline programs 5
News articles 0
Drug details — measles, mumps and rubella vaccine (live)
- Class
- Antiinfectives for systemic use (J07)
- Route
- —
- Patents
- 0
- Programs
- 5
- Data quality
- 0.83
Quick answer
measles, mumps and rubella vaccine (live) (M-M-RVAXPRO) is an FDA-listed pharmaceutical active ingredient.
Key facts
INN measles, mumps and rubella vaccine (live)
Brand M-M-RVAXPRO
Therapeutic class Antiinfectives for systemic use (J07)
ATC code J07BD52
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is measles, mumps and rubella vaccine (live)?
measles, mumps and rubella vaccine (live) (M-M-RVAXPRO) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for measles, mumps and rubella vaccine (live)?
M-M-RVAXPRO is a marketed brand name for measles, mumps and rubella vaccine (live). Check FDA Drugs@FDA for the current US label holder and prescribing information.